DELOGU, GIOVANNI
 Distribuzione geografica
Continente #
AS - Asia 4.157
NA - Nord America 3.929
SA - Sud America 1.205
EU - Europa 847
AF - Africa 310
Continente sconosciuto - Info sul continente non disponibili 220
OC - Oceania 4
Totale 10.672
Nazione #
US - Stati Uniti d'America 3.644
SG - Singapore 1.486
VN - Vietnam 919
BR - Brasile 878
CN - Cina 576
HK - Hong Kong 517
IT - Italia 406
BD - Bangladesh 287
ZA - Sudafrica 220
FR - Francia 192
AR - Argentina 129
CA - Canada 83
EC - Ecuador 71
IN - India 70
MX - Messico 70
ID - Indonesia 51
GB - Regno Unito 46
CO - Colombia 43
DE - Germania 42
RU - Federazione Russa 39
IQ - Iraq 34
PY - Paraguay 25
PH - Filippine 23
VE - Venezuela 23
TR - Turchia 22
CR - Costa Rica 18
NI - Nicaragua 18
MA - Marocco 17
PK - Pakistan 17
SA - Arabia Saudita 17
SC - Seychelles 17
UA - Ucraina 16
ES - Italia 14
JP - Giappone 14
TH - Thailandia 14
UZ - Uzbekistan 14
CW - ???statistics.table.value.countryCode.CW??? 13
GP - Guadalupe 13
IL - Israele 13
JM - Giamaica 13
NL - Olanda 13
PL - Polonia 13
SV - El Salvador 13
TT - Trinidad e Tobago 13
CL - Cile 12
GT - Guatemala 12
HN - Honduras 12
MY - Malesia 12
EG - Egitto 10
KE - Kenya 10
PE - Perù 10
DZ - Algeria 8
KZ - Kazakistan 8
SE - Svezia 8
TN - Tunisia 8
TW - Taiwan 8
UY - Uruguay 8
ET - Etiopia 7
IE - Irlanda 6
LT - Lituania 6
NP - Nepal 6
OM - Oman 6
AL - Albania 5
BH - Bahrain 5
CH - Svizzera 5
KR - Corea 5
PR - Porto Rico 5
AE - Emirati Arabi Uniti 4
AO - Angola 4
BO - Bolivia 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
EE - Estonia 4
FI - Finlandia 4
IR - Iran 4
JO - Giordania 4
MD - Moldavia 4
PS - Palestinian Territory 4
AM - Armenia 3
AU - Australia 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BW - Botswana 3
QA - Qatar 3
RS - Serbia 3
BB - Barbados 2
BE - Belgio 2
DM - Dominica 2
GR - Grecia 2
HT - Haiti 2
KG - Kirghizistan 2
KW - Kuwait 2
LV - Lettonia 2
MK - Macedonia 2
RO - Romania 2
SN - Senegal 2
SR - Suriname 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
BJ - Benin 1
Totale 10.451
Città #
San Jose 715
Dallas 539
Hong Kong 488
Council Bluffs 474
Singapore 439
Ashburn 416
Ho Chi Minh City 333
Hanoi 199
Johannesburg 198
Lauterbourg 176
Beijing 127
Boardman 99
Los Angeles 88
Santa Clara 85
São Paulo 77
Buffalo 68
Milan 59
New York 59
Rome 52
Da Nang 43
Phoenix 41
North Bergen 40
Mexico City 35
Haiphong 31
Columbus 29
Naples 26
Quito 25
Rio de Janeiro 25
Guayaquil 24
Brasília 23
Hefei 23
Munich 20
Belo Horizonte 18
Biên Hòa 18
Hải Dương 18
Managua 18
Atlanta 17
Parma 17
Shanghai 17
Baghdad 16
Montreal 16
Porto Alegre 16
Brooklyn 15
San José 15
Fortaleza 14
Thái Nguyên 14
Toronto 14
Can Tho 13
Curitiba 13
Salvador 13
Willemstad 13
Tashkent 12
Thái Bình 12
Bắc Ninh 11
Dhaka 11
Kingston 11
Bologna 10
Figino 10
Frankfurt am Main 10
Guangzhou 10
Guatemala City 10
Joinville 10
Philadelphia 10
San Salvador 10
Tianjin 10
Turin 10
Bogotá 9
Casablanca 9
Florence 9
Hyderabad 9
London 9
Nairobi 9
Ninh Bình 9
Orem 9
Warsaw 9
Bangkok 8
Brescia 8
Charlotte 8
Chennai 8
Jakarta 8
Jeddah 8
Quảng Ngãi 8
Seattle 8
Zhengzhou 8
Asunción 7
Boston 7
Chicago 7
Cuenca 7
Córdoba 7
Guarulhos 7
Ha Long 7
La Plata 7
Monte Grande 7
Montevideo 7
Santo André 7
Tokyo 7
Addis Ababa 6
Bauru 6
Buenos Aires 6
Cape Town 6
Totale 5.789
Nome #
Comprehensive Whole Genome Sequencing Dataset of Mycobacterium tuberculosis Strains Collected Across Italy 224
Prevalence of HPV Infection and p16INK4a Overexpression in Surgically Treated Laryngeal Squamous Cell Carcinoma 149
Comparative genomic analysis of bacteriocin genes in Lactobacillus crispatus strains 140
ADHESIVENESS OF BACILLUS-SUBTILIS STRAINS TO EPITHELIAL-CELLS CULTURED IN-VITRO 129
Current Evidence on the Relation Between Microbiota and Oral Cancer—The Role of Fusobacterium nucleatum—A Narrative Review 124
The activity of cell-free supernatant of Lactobacillus crispatus M247: a promising treatment against vaginal infections 112
The Potential Role of the Microbiome in the Pathogenesis of Nasal Tumors: A Comprehensive Review 112
Accuracy of p16 IHC in Classifying HPV-Driven OPSCC in Different Populations 106
Short-term gut microbiota’s shift after laparoscopic Roux-en-Y vs one anastomosis gastric bypass: results of a multicenter randomized control trial 99
Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children 94
Carbon nanomaterials: a new way against tuberculosis 91
Accuracy of QuantiFERON-TB Gold-PLUS Test for the Diagnosis of Mycobacterium tuberculosis Infection in Children 86
Multiple antimicrobial and immune-modulating activities of cysteamine in infectious diseases 85
Unraveling the potential of graphene quantum dots against Mycobacterium tuberculosis infection 82
Secrets and lies of host-microbial interactions: MHC restriction and trans-regulation of T cell trafficking conceal the role of microbial agents on the edge between health and multifactorial/complex diseases 81
Alternative therapies against Mycobacterium abscessus infections 81
A Repurposing Approach for Uncovering the Anti-Tubercular Activity of FDA-Approved Drugs with Potential Multi-Targeting Profiles 79
Specific immune response to M. tuberculosis and ability to in vitro control mycobacterial replication are not impaired in subjects with immune-mediated inflammatory disease and tuberculosis infection 78
Accuracy of QuantiFERON-TB Gold-PLUS Test for the Diagnosis of Mycobacterium tuberculosis infection in Children 77
Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for 'gut barrier protectors' in IBD? 76
Clinical isolates of the modern Mycobacterium tuberculosis lineage 4 evade host defense in human macrophages through eluding IL-1β-induced autophagy 76
Epidemic and pandemic viral infections: Impact on tuberculosis and the lung 76
Case Report: Multifocal Tubercular Osteomyelitis of the Spine and Bilateral Dactylitis 74
Host Directed Therapies for Tuberculosis: Futures Strategies for an Ancient Disease. 73
Graphene oxide coatings prevent Candida albicans biofilm formation with a controlled release of curcumin-loaded nanocomposites 72
3-(Benzodioxan-2-ylmethoxy)-2,6-difluorobenzamides bearing hydrophobic substituents at the 7-position of the benzodioxane nucleus potently inhibit methicillin-resistant Sa and Mtb cell division 72
Molecular typing of Mycobacterium tuberculosis strains: A fundamental tool for tuberculosis control and elimination 71
Clinical presentation, microbiological features and correlates of disease severity of 2009 pandemic influenza A (H1N1) infection 71
Detection of Mycobacterium tuberculosis DNA in CD34+ peripheral blood mononuclear cells of adults with tuberculosis infection and disease 70
HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker? 70
The spectrum of tuberculosis infection: new perspectives in the era of biologics 69
The PPE domain of PPE17 is responsible for its surface localization and can be used to express heterologous proteins on the mycobacterial surface. 69
C1q and HBHA-specific IL-13 levels as surrogate plasma biomarkers for monitoring tuberculosis treatment efficacy: a cross-sectional cohort study in Paraguay 66
HINTT working group within the GABRIEL network. (2020) Association of baseline white blood cell counts with tuberculosis treatment outcome: a prospective multicentered cohort study 66
Incidental intraoperative diagnosis of Mycobacterium abscessus meningeal infection: a case report and review of the literature 65
Toll-Like Receptor 2 Mediates In Vivo Pro- and Anti-inflammatory Effects of Mycobacterium Tuberculosis and Modulates Autoimmune Encephalomyelitis 64
Accuracy of QuantiFERON-TB Gold Test for Tuberculosis Diagnosis in Children 64
Low Prevalence of HPV Related Oropharyngeal Carcinogenesis in Northern Sardinia 64
Lifestyles and ageing: targeting key mechanisms to shift the balance from unhealthy to healthy ageing 64
HPV and EBV Infections in Neck Metastases from Occult Primary Squamous Cell Carcinoma: Another Virus-Related Neoplastic Disease in the Head and Neck Region 63
HPV as a marker for molecular characterization in head and neck oncology: Looking for a standardization of clinical use and of detection method(s) in clinical practice 63
The biology of mycobacterium tuberculosis infection 62
Clinical applicability of Quantiferon-TB-Gold testing in psoriasis patients during long-term anti-TNF-alpha treatment: a prospective, observational study 62
Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice. 61
In vitro effect of unacylated ghrelin and obestatin on human luteal cell function 61
Vaccine effectiveness against severe laboratory-confirmed influenza in children: results of two consecutive seasons in Italy 61
HPV as a marker for molecular characterization in head and neck oncology: Looking for a standardization of clinical use and of detection method(s) in clinical practice 60
Mycobacterium tuberculosis virulence: insights and impact on vaccine development 60
Immunomodulation by gut microbiota: role of Toll-like receptor expressed by T cells 60
Unraveling the Gut Microbiome–Diet Connection: Exploring the Impact of Digital Precision and Personalized Nutrition on Microbiota Composition and Host Physiology 60
Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients 59
Characterization of gut microbiota in patients with metabolic syndrome candidates for bariatric/metabolic surgery: Preliminary findings of a multi-center prospective study 59
PE_PGRS33 Contributes to Mycobacterium tuberculosis Entry in Macrophages through Interaction with TLR2 59
Specific T Cells Restore the Autophagic Flux Inhibited by Mycobacterium tuberculosis in Human Primary Macrophages 58
The role of IGRA in the diagnosis of tuberculosis infection, differentiating from active tuberculosis, and decision making for initiating treatment or preventive therapy of tuberculosis infection 58
Intranasal delivery of DNA encoding antigens of Mycobacterium tuberculosis by non-pathogenic invasive Escherichia coli 57
3D-printed graphene polylactic acid devices resistant to SARS-CoV-2: Sunlight-mediated sterilization of additive manufactured objects 57
Bacillus cereus keratitis associated with contact lens wear 57
Transglutaminase 2 Regulates Innate Immunity by Modulating the STING/TBK1/IRF3 Axis 57
Functional dissection of protein domains involved in the immunomodulatory properties of PE_PGRS33 of Mycobacterium tuberculosis 57
Development of antitubercular compunds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studies 57
Oral delivery of a DNA vaccine against tuberculosis using operator-repressor titration in a Salmonella enterica vector 56
M tuberculosis in the adjuvant modulates time of appearance of CNS-specific effector T cells in the spleen through a polymorphic site of TLR2. 55
Lack of Response to HBHA in HIV-Infected Patients with Latent Tuberculosis Infection 55
Children and COVID-19: Microbiological and immunological insights 55
Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy 55
Cysteamine exerts in vitro antiviral activity against the SARS-CoV-2 Delta and Omicron variants 55
In-Depth Immunophenotyping With Mass Cytometry During TB Treatment Reveals New T-Cell Subsets Associated With Culture Conversion 55
Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients 54
Laser-Mediated antibacterial effects of Few- and Multi-Layer Ti3C2Tx MXenes 54
Tuberculosis patients are characterized by a low-IFN-gamma/high-TNF-alpha response to methylated HBHA produced in M. smegmatis 54
Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infection 54
Vaccine effectiveness against severe laboratory-confirmed influenza in children: results of two consecutive seasons in Italy 53
Prospective Evaluation of Epidemiological, Clinical, and Microbiological Features of Pandemic Influenza A (H1N1) Virus Infection in Italy 53
Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences 52
PPE_MPTR genes are differentially expressed by Mycobacterium tuberculosis in vivo 52
A Twenty-year Retrospective Study of Pediatric Tuberculosis in Two Tertiary Hospitals in Rome 52
Transglutaminase type 2 plays a key role in the pathogenesis of Mycobacterium tuberculosis infection 52
Development of Potent Inhibitors of the Mycobacterium tuberculosis Virulence Factor Zmp1 and Evaluation of Their Effect on Mycobacterial Survival inside Macrophages 52
Graphene Oxide-Linezolid Combination as Potential New Anti-Tuberculosis Treatment 51
First description of the katG gene deletion in a Mycobacterium tuberculosis clinical isolate and its impact on the mycobacterial fitness 51
Structural Basis of PE_PGRS Polymorphism, a Tool for Functional Modulation 51
Development of Potent Inhibitors of the Mycobacterium tuberculosis Virulence Factor Zmp1 and Evaluation of Their Effect on Mycobacterial Survival inside Macrophages 51
Monocyte‐to‐lymphocyte, neutrophil‐to‐lymphocyte and neutrophil‐to‐monocyte plus lymphocyte ratios in children with active tuberculosis: A multicentre study 51
First description of agonist and antagonist IP-10 in urine of patients with active TB 51
Recombinant BCG-Rv1767 amount determines, in vivo, antigen-specific T cells location, frequency, and protective outcome 50
Critical Research Concepts in TB Vaccine Development. 50
PE_PGRS33, an Important Virulence Factor of Mycobacterium tuberculosis and Potential Target of Host Humoral Immune Response 50
HIV-infected patients show impaired cellular immune response to influenza vaccination, compared to healthy subjects 50
PE_PGRS proteins of Mycobacterium tuberculosis: A specialized molecular task force at the forefront of host-pathogen interaction 50
Commercially available CD4 + and CD8 + IFN-γ release assays combined with an HBHA-induced IGRA improve the characterization of the tuberculosis spectrum and monitoring of treatment in children 50
Isolation and identification of Mycobacterium neoaurum from a patient with urinary infection 50
QuantiFERON TB Gold: a new method for latent tuberculosis infection 49
Exploiting the mycobacterial cell wall to design improved vaccines against tuberculosis 49
Recovering or Persisting: The Immunopathological Features of SARS-CoV-2 Infection in Children. On Behalf Of The Gemelli-Pediatric Covid-Team 49
Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children 49
Understanding cutaneous tuberculosis: two clinical cases 49
Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infection 49
Suspected transmission of tuberculosis in a maternity ward from a smear-positive nurse: preliminary results of clinical evaluations and testing of neonates potentially exposed, Rome, Italy, 1 January to 28 July 2011 49
Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection 48
Totale 6.744
Categoria #
all - tutte 33.934
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.934


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224 0 0 0 0 0 1 0 0 0 0 1 2
2022/20234 1 0 0 0 0 0 0 0 3 0 0 0
2023/20241 0 0 0 0 0 0 0 0 0 0 0 1
2024/2025822 0 1 1 0 0 1 2 1 2 1 237 576
2025/20267.451 209 965 1.398 886 777 252 693 261 920 433 386 271
2026/20272.387 408 511 484 841 143 0 0 0 0 0 0 0
Totale 10.672